The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Open accessAbstract
Long-term in vivo expression of a broad and potent entry inhibitor could circumvent the need for a conventional vaccine for HIV-1. Adeno-associated virus (AAV) vectors can stably express HIV-1 broadly neutralizing antibodies (bNAbs). However, even the best bNAbs neutralize 10–50% of HIV-1 isolates inefficiently (80% inhibitory concentration (IC80) > 5 μg ml−1), suggesting that high concentrations of these antibodies would be necessary to achieve general protection. Here we show that eCD4-Ig, a fusion of CD4-Ig with a small CCR5-mimetic sulfopeptide, binds avidly and cooperatively to the HIV-1 envelope glycoprotein (Env) and is more potent than the best bNAbs (geometric mean half-maximum inhibitory concentration (IC50) < 0.05 μg ml−1). Because eCD4-Ig binds only conserved regions of Env, it is also much broader than any bNAb. For example, eCD4-Ig efficiently neutralized 100% of a diverse panel of neutralization-resistant HIV-1, HIV-2 and simian immunodeficiency virus isolates, including a comprehensive set of isolates resistant to the CD4-binding site bNAbs VRC01, NIH45-46 and 3BNC117. Rhesus macaques inoculated with an AAV vector stably expressed 17–77 μg ml−1 of fully functional rhesus eCD4-Ig for more than 40 weeks, and these macaques were protected from several infectious challenges with SHIV-AD8. Rhesus eCD4-Ig was also markedly less immunogenic than rhesus forms of four well-characterized bNAbs. Our data suggest that AAV-delivered eCD4-Ig can function like an effective HIV-1 vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
Self-citationRational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationWei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
Self-citationBroad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Self-citationConnor, R. I., Chen, B. K., Choe, S., & Landau, N. R. (1995) · Virology · doi:10.1006/viro.1995.1016 · Cited by 1,253
Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2855-2864.1998 · Cited by 1,219
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Self-citationLi, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationHe, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., & Landau, N. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6705-6711.1995 · Cited by 904
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., et al. (2012) · Nature · doi:10.1038/nature11544 · Cited by 828
Self-citationA Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1949 · Cited by 812
Self-citation‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization
Ridgway, J. B. B., Presta, L. G., & Carter, P. (1996) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/9.7.617 · Cited by 810
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8358-8367.2000 · Cited by 742
Self-citationTyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry
Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R., Cayabyab, M., Gerard, N. P., Gerard, C., Sodroski, J., & Choe, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80577-2 · Cited by 693
Self-citationHolt, N., Wang, J., Kim, K., Friedman, G., Wang, X., Taupin, V., Crooks, G. M., Kohn, D. B., Gregory, P. D., Holmes, M. C., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1663 · Cited by 677
Self-citationSeaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02108-09 · Cited by 632
Self-citationAntibody-based protection against HIV infection by vectored immunoprophylaxis
Balazs, A. B., Chen, J., Hong, C. M., Rao, D. S., Yang, L., & Baltimore, D. (2012) · Nature · doi:10.1038/nature10660 · Cited by 545
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Shingai, M., Nishimura, Y., Klein, F., Mouquet, H., Donau, O. K., Plishka, R., Buckler-White, A., Seaman, M., Piatak, M., Lifson, J. D., et al. (2013) · Nature · doi:10.1038/nature12746 · Cited by 455
Self-citationA soluble CD4 protein selectively inhibits HIV replication and syncytium formation
Hussey, R. E., Richardson, N. E., Kowalski, M., Brown, N. R., Chang, H.-C., Siliciano, R. F., Dorfman, T., Walker, B., Sodroski, J., & Reinherz, E. L. (1988) · Nature · doi:10.1038/331078a0 · Cited by 427
Self-citationStructures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4
Huang, C.-C., Lam, S. N., Acharya, P., Tang, M., Xiang, S.-H., Hussan, S. S.-U., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., et al. (2007) · Science · doi:10.1126/science.1145373 · Cited by 416
Self-citationIncreasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Diskin, R., Scheid, J. F., Marcovecchio, P. M., West, A. P., Klein, F., Gao, H., Gnanapragasam, P. N. P., Abadir, A., Seaman, M. S., Nussenzweig, M. C., et al. (2011) · Science · doi:10.1126/science.1213782 · Cited by 375
Self-citationSauer-Eriksson, A. E., Kleywegt, G. J., Uhlén, M., & Jones, T. A. (1995) · Structure · doi:10.1016/s0969-2126(01)00157-5 · Cited by 372
Mörner, A., Björndal, Å., Albert, J., KewalRamani, V. N., Littman, D. R., Inoue, R., Thorstensson, R., Fenyö, E. M., & Björling, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2343-2349.1999 · Cited by 328
Johnson, P. R., Schnepp, B. C., Zhang, J., Connell, M. J., Greene, S. M., Yuste, E., Desrosiers, R. C., & Reed Clark, K. (2009) · Nature Medicine · doi:10.1038/nm.1967 · Cited by 310
Self-citationHuang, C.-C., Venturi, M., Majeed, S., Moore, M. J., Phogat, S., Zhang, M.-Y., Dimitrov, D. S., Hendrickson, W. A., Robinson, J., Sodroski, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308527100 · Cited by 275
Self-citationTakeuchi, Y., McClure, M. O., & Pizzato, M. (2008) · Journal of Virology · doi:10.1128/jvi.01726-08 · Cited by 246
Rouet, F., Ekouevi, D. K., Chaix, M.-L., Burgard, M., Inwoley, A., Tony, T. D., Danel, C., Anglaret, X., Leroy, V., Msellati, P., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2709-2717.2005 · Cited by 234
Platt, E. J., Bilska, M., Kozak, S. L., Kabat, D., & Montefiori, D. C. (2009) · Journal of Virology · doi:10.1128/jvi.00709-09 · Cited by 233
Choe, H., Li, W., Wright, P. L., Vasilieva, N., Venturi, M., Huang, C.-C., Grundner, C., Dorfman, T., Zwick, M. B., Wang, L., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00508-7 · Cited by 214
Self-citationChoe, H., Farzan, M., Konkel, M., Martin, K., Sun, Y., Marcon, L., Cayabyab, M., Berman, M., Dorf, M. E., Gerard, N., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.6113-6118.1998 · Cited by 198
Self-citationStructural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation
Tran, E. E. H., Borgnia, M. J., Kuybeda, O., Schauder, D. M., Bartesaghi, A., Frank, G. A., Sapiro, G., Milne, J. L. S., & Subramaniam, S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002797 · Cited by 195
Farzan, M., Choe, H., Vaca, L., Martin, K., Sun, Y., Desjardins, E., Ruffing, N., Wu, L., Wyatt, R., Gerard, N., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1160-1164.1998 · Cited by 188
Self-citationAlpert, M. D., Harvey, J. D., Lauer, W. A., Reeves, R. K., Piatak, M., Carville, A., Mansfield, K. G., Lifson, J. D., Li, W., Desrosiers, R. C., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002890 · Cited by 180
Self-citationHaim, H., Si, Z., Madani, N., Wang, L., Courter, J. R., Princiotto, A., Kassa, A., DeGrace, M., McGee-Estrada, K., Mefford, M., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000360 · Cited by 169
Barouch, D. H., Yang, Z.-Y., Kong, W.-P., Korioth-Schmitz, B., Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Miura, A., Mascola, J. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8828-8834.2005 · Cited by 160
Moebius, U., Clayton, L. K., Abraham, S., Harrison, S. C., & Reinherz, E. L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.507 · Cited by 159
Farzan, M. R., Vasilieva, N. Y., Schnitzler, C. E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007228200 · Cited by 142
Self-citationSullivan, N. J., Sun, Y., Binley, J. Μ., Lee, J., Barbas, C. F., Parren, P. W. H. I., Burton, D. R., & Sodroski, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6332-6338.1998 · Cited by 130
Self-citationAlpert, M. D., Heyer, L. N., Williams, D. E. J., Harvey, J. D., Greenough, T. C., Allhorn, M., & Evans, D. T. (2012) · Journal of Virology · doi:10.1128/jvi.01650-12 · Cited by 129
Self-citationLewis, A. D., Chen, R., Montefiori, D. C., Johnson, P. R., & Clark, K. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8769-8775.2002 · Cited by 124
Dorfman, T., Moore, M. J., Guth, A. C., Choe, H., & Farzan, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602732200 · Cited by 65
Self-citationGreig, J. A., Peng, H., Ohlstein, J. F., Medina-Jaszek, C. A., Ahonkhai, O., Mentzinger, A., Grant, R. L., Roy, S., Chen, S., Bell, P. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112268 · Cited by 59
Enhanced Recognition and Neutralization of HIV-1 by Antibody-Derived CCR5-Mimetic Peptide Variants
Chiang, J. J., Gardner, M. R., Quinlan, B. D., Dorfman, T., Choe, H., & Farzan, M. (2012) · Journal of Virology · doi:10.1128/jvi.00967-12 · Cited by 23
Self-citation
Cited by
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
Self-citationNanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Bannas, P., Hambach, J., & Koch-Nolte, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01603 · Cited by 572
“For example, intramuscular injection of AAV encoding HIV-neutralizing antibodies or a CD4–Fc fusion protein led to long-term production of the encoded antibodies and protection of mice from HIV infection (131, 132).”
BackgroundInternational AIDS Society global scientific strategy: towards an HIV cure 2016
International AIDS Society Towards a Cure Working Group, Deeks, S. G., Lewin, S. R., Ross, A. L., Ananworanich, J., Benkirane, M., Cannon, P., Chomont, N., Douek, D., Lifson, J. D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4108 · Cited by 425
Self-citationDesign of virus-based nanomaterials for medicine, biotechnology, and energy
Wen, A. M., & Steinmetz, N. F. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00287g · Cited by 379
A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
Park, R. J., Wang, T., Koundakjian, D., Hultquist, J. F., Lamothe-Molina, P., Monel, B., Schumann, K., Yu, H., Krupzcak, K. M., Garcia-Beltran, W., et al. (2017) · Nature Genetics · doi:10.1038/ng.3741 · Cited by 333
Metadata
- Authors
- Gardner, M. R., Kattenhorn, L. M., Kondur, H. R., von Schaewen, M., Dorfman, T., Chiang, J. J., Haworth, K. G., Decker, J. M., Alpert, M. D., Bailey, C. C., Neale, E. S., Fellinger, C. H., Joshi, V. R., Fuchs, S. P., Martinez-Navio, J. M., Quinlan, B. D., Yao, A. Y., Mouquet, H., Gorman, J., Zhang, B., Poignard, P., Nussenzweig, M. C., Burton, D. R., Kwong, P. D., Piatak, M., Lifson, J. D., Gao, G., Desrosiers, R. C., Evans, D. T., Hahn, B. H., Ploss, A., Cannon, P. M., Seaman, M. S., & Farzan, M.
- Venue
- Nature
- Published
- 2015-02-18
- Volume
- 519
- Issue
- 7541
- Pages
- 87-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2073383703
- Cited by
- 298
- References
- 43
- FWCI
- 25.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.